Sign in
4

Changes in Ownership

Edwards Lifesciences Corp Filed Acc 0001225208-23-008709

Director sold 29,350 shares at $75.86 ($2,226,491)

  • Director acquired 29,350 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

MUSSALLEM MICHAEL A · Director

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2023-09-05 Exercise or conversion : show line 1 in the form 10b5-1 +29,350 $36.75 $1,078,613 33,835.82 D
2023-09-05 Sale : show line 2 in the form 10b5-1 −29,350 $75.86 $2,226,491 4,485.82 D
Open-market sales · 29,350 sh · avg $75.86 · $2,226,491

Table II: Derivative

1 line
Date Transaction Shares Exercise Expires Underlying Owned after D/I
2023-09-05 Exercise or conversion : show line 3 in the form 10b5-1 Employee Stock Option (Right to Acquire) −29,350 $36.75 2024-05-10 29,350 234,800 D
Loading xslF345X05/doc4.xml…